Skip to main content
. 2015 Aug 18;10(8):e0135205. doi: 10.1371/journal.pone.0135205

Fig 1. Overall drug resistance (%) in TB patients with and without COPD.

Fig 1

(INH, isoniazid; RFP, rifampicin; MDR, multidrug-resistant; EMB, ethambutol; SM, streptomycin; KM, kanamycin; CPM, capreomycin; OFLX, ofloxacin; MDR+OFLX, MDR plus resistance to ofloxacin; MDR+SLID, MDR plus resistance to second line injectable drugs; XDR, extensively drug-resistant; PAS, para-aminosalicylic acid).